miR-548e-3p 在结直肠癌中的表达及意义
摘要
关键词
全文:
PDF参考
[1]CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global
cancer statistics 2020 [J]. Chin Med J (Engl), 2021, 134(7): 783-91.
[2]ZHOU J, ZHENG R, ZHANG S, et al. Colorectal cancer burden and trends: Comparison between China and major burden countries in
the world [J]. Chin J Cancer Res, 2021, 33(1): 1-10.
[3]JAHANAFROOZ Z, MOSAFER J, AKBARI M, et al. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment [J]. J Cell Physiol, 2020, 235(5): 4153-66.
[4]ZENG H, CHEN W, ZHENG R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries [J]. The Lancet Global Health, 2018, 6(5): e555-e67.
[5]ARNOLD M, SIERRA M S, LAVERSANNE M, et al. Global patterns and trends in colorectal cancer incidence and mortality [J]. Gut, 2017, 66(4): 683-91.
[6]GEBERT L F R, MACRAE I J. Regulation of microRNA function in animals [J]. Nat Rev Mol Cell Biol, 2019, 20(1): 21-37.
[7]FUJIWARA T, YADA T. miRNA-target prediction based on transcriptional regulation [J]. BMC Genomics, 2013, 14 Suppl 2(Suppl 2): S3.
[8]CHEN X, ZHANG D H, YOU Z H. A heterogeneous label propagation approach to explore the potential associations between miRNA and disease [J]. J Transl Med, 2018, 16(1): 348.
[9]FORCE U S P S T, BIBBINS-DOMINGO K, GROSSMAN D C, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement [J]. JAMA, 2016, 315(23): 2564-75.
[10]JESS T. Thiopurines for inflammatory bowel disease: time to engage with dermatologists? [J]. Gastroenterology, 2011, 141(5): 1549-51.
[11]LADABAUM U, MANNALITHARA A. 860 Cost-Effectiveness of Colorectal Cancer (CRC) Screening With a Multitarget Stool DNA Assay (FIT-DNA) vs. Fecal Immunochemical Testing (FIT) or Colonoscopy [J]. Gastroenterology, 2016, 150(4): S184-S5.
[12]SHAUKAT A, RECTOR T S, CHURCH T R, et al. Longer Withdrawal Time Is Associated With a Reduced Incidence of Interval Cancer After Screening Colonoscopy [J]. Gastroenterology, 2015, 149(4): 952-7.
[13]INADOMI J M, SOMSOUK M A. Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening? [J]. Gastroenterology, 2007, 133(4): 1384-5; discussion 5-6.
[14]RUTTER M D, BEINTARIS I, VALORI R, et al. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer [J]. Gastroenterology, 2018, 155(3): 909-25 e3.
[15]NERAD E, LAHAYE M J, MAAS M, et al. Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis [J]. AJR Am J Roentgenol, 2016, 207(5): 984-95.
[16]LABIANCA R, NORDLINGER B, BERETTA G D, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2013, 24 Suppl 6: vi64-72.
[17]JORGE A L, PEREIRA E R, OLIVEIRA C S, et al. MicroRNAs: understanding their role in gene expression and cancer [J]. Einstein (Sao Paulo), 2021, 19: eRB5996.
[18]WAN G, LIM Q E, TOO H P. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers [J]. RNA, 2010, 16(7): 1436-45.
[19]SCHWARZENBACH H, NISHIDA N, CALIN G A, et al. Clinical relevance of circulating cell-free microRNAs in cancer [J]. Nat Rev Clin Oncol, 2014, 11(3): 145-56.
[20]SHI H, XU J, ZHANG G, et al. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes [J]. BMC Syst Biol, 2013, 7: 101.
[21]KAWAGUCHI T, KOMATSU S, ICHIKAWA D, et al. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers [J]. Int J Mol Sci, 2016, 17(9).
[22]LIZ J, ESTELLER M. lncRNAs and microRNAs with a role in cancer development [J]. Biochim Biophys Acta, 2016, 1859(1):
169-76.
[23]SHIRJANG S, MANSOORI B, MOHAMMADI A, et al. miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1 [J].
Adv Pharm Bull, 2020, 10(3): 444-51.
[24]MA H, LIU T, XU Y, et al. MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression [J]. Onco Targets Ther,
2020, 13: 12987-97.
(15 摘要 Views, 6 PDF Downloads)
Refbacks
- 当前没有refback。